Sab Biotherapeutics Inc. (SABS)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 54
-0.12
-3.4106%
$
34.41M Market Cap
0.1 P/E Ratio
- Div Yield
678,400 Volume
0 Eps
$ 3.67
Previous Close 
Want to track SABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
SABS Earnings Reports FAQ
What is the earnings per share (EPS) for SABS?
The current EPS is 0.
What is the company's earnings growth rate?
Sab Biotherapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Sab Biotherapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Sab Biotherapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for SABS at this time, as Sab Biotherapeutics Inc has no recent EPS data to calculate it.
